ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

BCRX BioCryst Pharmaceuticals Inc

4.55
0.42 (10.17%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
BioCryst Pharmaceuticals Inc BCRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.42 10.17% 4.55 09:56:14
Open Price Low Price High Price Close Price Previous Close
4.18 4.15 4.77 4.57 4.13
more quote information »

Recent News

Date Time Source Heading
22/4/202421:00GLOBEBioCryst to Report First Quarter 2024 Financial Results on..
17/4/202418:30GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
03/4/202422:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
26/3/202407:01GLOBEBioCryst to Present at Upcoming Investor Conferences
05/3/202423:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
05/3/202409:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202408:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202409:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26/2/202423:05EDGAR2Form 8-K - Current report
26/2/202423:00GLOBEBioCryst Reports Fourth Quarter and Full Year 2023 Financial..
26/2/202421:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
23/2/202423:00GLOBEBioCryst Presents New Real-world Data Showing Rapid,..
22/2/202408:01GLOBEBioCryst to Present at Upcoming Investor Conferences
19/2/202423:54GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Italy
15/2/202408:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202401:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202423:00GLOBEBioCryst to Report Fourth Quarter 2023 Financial Results on..
05/2/202423:00GLOBEBioCryst to Present New ORLADEYO® (berotralstat) Real-world..
02/2/202423:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
25/1/202409:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202409:21EDGAR2Form 8-K - Current report
08/1/202423:02EDGAR2Form 8-K - Current report
06/1/202408:01GLOBEBioCryst Announces Preliminary Full Year 2023 ORLADEYO®..
05/1/202408:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
03/1/202423:00GLOBEBioCryst to Present at 42nd Annual J.P. Morgan Healthcare..
21/12/202308:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:00GLOBEBioCryst Announces Publication of Data from Open-label..
19/12/202308:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202308:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202308:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202308:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202308:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202308:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
02/12/202308:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202308:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202323:37EDGAR2Form 8-K - Current report
01/12/202301:04EDGAR2Form 8-K - Current report
29/11/202323:00GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
22/11/202308:01GLOBEBioCryst to Present at Upcoming Investor Conferences
21/11/202323:00GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Spain
10/11/202323:00GLOBEBioCryst Presents New Real-world Data Showing Reduced Attack..
09/11/202308:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202308:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202308:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
04/11/202303:16EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock